Ohira Shingo, Ueda Yoshihiro, Hashimoto Misaki, Miyazaki Masayoshi, Isono Masaru, Kamikaseda Hiroshi, Masaoka Akira, Takashina Masaaki, Koizumi Masahiko, Teshima Teruki
Department of Radiation Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Nakamichi 1-3-3, Higashinari-ku, Osaka, 537-8511, Japan Department of Medical Physics and Engineering, Osaka University Graduate School of Medicine, Suita, Japan.
Department of Radiation Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Nakamichi 1-3-3, Higashinari-ku, Osaka, 537-8511, Japan Department of Radiation Oncology, Osaka University Graduate School of Medicine, Suita, Japan.
J Radiat Res. 2016 Jan;57(1):91-7. doi: 10.1093/jrr/rrv058. Epub 2015 Sep 28.
The aim of the this study was to validate the use of an average intensity projection (AIP) for volumetric-modulated arc therapy for stereotactic body radiation therapy (VMAT-SBRT) planning for a moving lung tumor located near the diaphragm. VMAT-SBRT plans were created using AIPs reconstructed from 10 phases of 4DCT images that were acquired with a target phantom moving with amplitudes of 5, 10, 20 and 30 mm. To generate a 4D dose distribution, the static dose for each phase was recalculated and the doses were accumulated by using the phantom position known for each phase. For 10 patients with lung tumors, a deformable registration was used to generate 4D dose distributions. Doses to the target volume obtained from the AIP plan and the 4D plan were compared, as were the doses obtained from each plan to the organs at risk (OARs). In both phantom and clinical study, dose discrepancies for all parameters of the dose volume (D(min), D(99), D(max), D(1) and D(mean)) to the target were <3%. The discrepancies of D(max) for spinal cord, esophagus and heart were <1 Gy, and the discrepancy of V20 for lung tissue was <1%. However, for OARs with large respiratory motion, the discrepancy of the D(max) was as much as 9.6 Gy for liver and 5.7 Gy for stomach. Thus, AIP is clinically acceptable as a planning CT image for predicting 4D dose, but doses to the OARs with large respiratory motion were underestimated with the AIP approach.
本研究的目的是验证平均强度投影(AIP)在容积调强弧形放疗(VMAT)用于立体定向体部放射治疗(SBRT)计划中的应用,该计划针对位于膈肌附近的移动性肺肿瘤。VMAT-SBRT计划是使用从4DCT图像的10个时相重建的AIP创建的,这些图像是在目标体模以5、10、20和30mm的幅度移动时采集的。为了生成4D剂量分布,重新计算每个时相的静态剂量,并使用每个时相已知的体模位置累积剂量。对于10例肺肿瘤患者,使用可变形配准生成4D剂量分布。比较了从AIP计划和4D计划获得的靶区剂量,以及从每个计划获得的危及器官(OARs)剂量。在体模和临床研究中,靶区剂量体积的所有参数(D(min)、D(99)、D(max)、D(1)和D(mean))的剂量差异均<3%。脊髓、食管和心脏的D(max)差异<1Gy,肺组织的V20差异<1%。然而,对于呼吸运动较大的OARs,肝脏的D(max)差异高达9.6Gy,胃的差异高达5.7Gy。因此,AIP作为预测4D剂量的计划CT图像在临床上是可接受的,但AIP方法低估了呼吸运动较大的OARs的剂量。